Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-08-08

Alan Baltz

Resident Physician

Also affiliated: Winthrop Rockefeller Foundation (2023); Central Arkansas Radiation Therapy Institute (2022); Arkansas Department of Agriculture (2023)

Faculty Researcher

4 h-index 19 pubs 60 cited

  • Humans
  • Aged
  • Female
  • Antiemetics
  • Antineoplastic Agents
  • Nausea
  • Vomiting
  • Medical Marijuana
  • Text Messaging
  • Drug Overdose
  • Breast Neoplasms
  • Male
  • Middle Aged
  • Retrospective Studies
  • Legislation, Drug

Biography and Research Information

OverviewAI-generated summary

Alan Baltz, a resident physician at the University of Arkansas for Medical Sciences, researches various aspects of cancer treatment and patient outcomes. His work includes analyzing the clinical impact of established guidelines on staging imaging for early-stage breast cancers, utilizing SEER-Medicare data to conduct time-series analyses. Baltz has also investigated the real-world survival outcomes for patients receiving CAR-T and bispecific T-cell engagers for relapsed/refractory diffuse large B-cell lymphoma. His research extends to understanding the impact of the CAR-T era on survival in this patient population through U.S. population-based cohort studies.

Further contributing to the field, Baltz's publications address the safety and effectiveness of specific drugs through systematic literature reviews, such as for Benzonatate. He also explores predictive factors for survival in certain hematological malignancies, including analyzing epidemiological and clinical trends from the Arkansas Central Cancer Registry. Baltz collaborates with researchers including Ankur Varma and Mamatha Gaddam, with whom he shares multiple publications.

Metrics

  • h-index: 4
  • Publications: 19
  • Citations: 60

Selected Publications

  • In vivo CAR T-cell engineering in B-cell malignancies: A systematic review of emerging clinical and translational evidence. (2026)
    Journal of Clinical Oncology DOI OpenAlex
  • Social vulnerability index as an independent poor prognostic factor in patients with chronic hematological malignancies in Arkansas. (2026)
    Journal of Clinical Oncology DOI OpenAlex
  • Real-World Survival Outcomes of CAR-T and Bispecific T-cell Engagers in Patients with relapsed/refractory DLBCL (2026)
    Transplantation and Cellular Therapy DOI OpenAlex
  • Impact of the CAR-T era on survival in diffuse large B-cell lymphoma: A u.S. population-based cohort study (2025)
    Blood DOI OpenAlex
  • Can the development of drug-induced rash after mogamulizumab administration predict survival in mycosis fungoides/sezary syndrome? a trinetx-based analysis (2025)
    Blood DOI OpenAlex
  • Epidemiological and clinical trends in common hematological malignancies in Arkansas: Arkansas Central Cancer Registry (ACCR)-based study. (2025)
    Journal of Clinical Oncology DOI OpenAlex
  • Impact of Social Vulnerability Index and Travel Distance on Access to Chimeric Antigen Receptor T-Cell Therapy (2024)
    Blood DOI OpenAlex
  • Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021) (2024)
    Blood DOI OpenAlex
  • Association Between Medical Marijuana Cardholder Status and Antiemetic Overuse (2024)
    Cannabis and Cannabinoid Research DOI OpenAlex
  • Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity (2023)
    Cancers 31 citations DOI OpenAlex
  • Participation in a multidisciplinary institutional committee, “RQUEST,” to enhance quality improvement education, project design, and implementation for hematology/oncology fellows. (2023)
    Journal of Clinical Oncology DOI OpenAlex
  • Exploring the association between medical marijuana cardholder status and antiemetic overuse. (2023)
    Journal of Clinical Oncology DOI OpenAlex
  • Benzonatate Safety and Effectiveness: A Systematic Review of the Literature (2023)
    Annals of Pharmacotherapy 6 citations DOI OpenAlex
  • Exploring the Use of State Medical Cannabis Legislation as a Proxy for Medical Cannabis Use Among Patients Receiving Chemotherapy (2020)
    Current Treatment Options in Oncology 4 citations DOI OpenAlex
  • The clinical impact of ASCO “choosing wisely” recommendations on staging imaging for early stage breast cancers: An interrupted time-series analysis utilizing SEER-Medicare data. (2020)
    Journal of Clinical Oncology 2 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

43 Collaborators 7 Institutions 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics